Pages that link to "Q34655173"
Jump to navigation
Jump to search
The following pages link to Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension (Q34655173):
Displaying 20 items.
- Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension (Q28265281) (← links)
- Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost (Q28305613) (← links)
- Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension (Q34043309) (← links)
- Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: A preliminary study (Q34545031) (← links)
- Achieving low target pressures with today's glaucoma medications (Q35174009) (← links)
- Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension (Q35562610) (← links)
- Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension (Q36414819) (← links)
- The side effects of the prostaglandin analogues (Q36689066) (← links)
- Efficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertension (Q37030858) (← links)
- Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension (Q37394089) (← links)
- Bimatoprost - a review (Q37623833) (← links)
- Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: A prospective, open-label, randomized, two-arm, parallel-group study (Q37660978) (← links)
- Ocular surface cytotoxicity and safety evaluation of tafluprost, a recently developed anti-glaucoma prostaglandin analog (Q38190054) (← links)
- Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study (Q41828491) (← links)
- Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides (Q42943389) (← links)
- A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study (Q44420267) (← links)
- A novel convergent synthesis of the antiglaucoma PGF2α analogue bimatoprost. (Q44637557) (← links)
- Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages. (Q47381165) (← links)
- A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost. (Q53535046) (← links)
- Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work (Q92674148) (← links)